Inflection Point Investments LLP Acquires Shares of 156,899 Integral Ad Science Holding Corp. (NASDAQ:IAS)

Inflection Point Investments LLP purchased a new stake in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 156,899 shares of the company's stock, valued at approximately $1,265,000. Integral Ad Science accounts for about 2.8% of Inflection Point Investments LLP's investment portfolio, making the stock its 9th biggest holding. Inflection Point Investments LLP owned approximately 0.10% of Integral Ad Science as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of IAS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Integral Ad Science by 4.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,519 shares of the company's stock worth $433,000 after acquiring an additional 1,832 shares during the last quarter. Oppenheimer & Co. Inc. lifted its position in Integral Ad Science by 8.0% during the 4th quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company's stock worth $293,000 after acquiring an additional 2,069 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in Integral Ad Science by 7.4% during the 4th quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company's stock worth $332,000 after acquiring an additional 2,188 shares during the last quarter. Arizona State Retirement System lifted its position in Integral Ad Science by 12.5% during the 4th quarter. Arizona State Retirement System now owns 23,404 shares of the company's stock worth $244,000 after acquiring an additional 2,601 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its position in Integral Ad Science by 8.9% during the 4th quarter. Victory Capital Management Inc. now owns 32,880 shares of the company's stock worth $343,000 after acquiring an additional 2,695 shares during the last quarter. 95.78% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,367 shares of the company's stock in a transaction dated Wednesday, May 7th. The shares were sold at an average price of $7.37, for a total transaction of $61,664.79. Following the sale, the chief executive officer now directly owns 349,574 shares of the company's stock, valued at approximately $2,576,360.38. This represents a 2.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold a total of 86,222 shares of company stock valued at $636,252 over the last quarter. 2.00% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

IAS has been the subject of a number of research analyst reports. Morgan Stanley cut their target price on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Truist Financial boosted their price objective on shares of Integral Ad Science from $16.00 to $17.00 and gave the stock a "buy" rating in a report on Monday, March 3rd. Stifel Nicolaus reduced their target price on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Raymond James lifted their target price on Integral Ad Science from $11.00 to $13.00 and gave the stock an "outperform" rating in a research report on Tuesday, May 13th. Finally, Baird R W cut Integral Ad Science from a "strong-buy" rating to a "hold" rating in a report on Friday, March 28th. Seven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $13.55.

Integral Ad Science Price Performance

NASDAQ IAS traded down $0.11 on Friday, reaching $8.15. The company's stock had a trading volume of 1,799,574 shares, compared to its average volume of 998,754. The firm has a market cap of $1.34 billion, a PE ratio of 40.75, a price-to-earnings-growth ratio of 1.06 and a beta of 1.59. The business has a 50-day moving average price of $7.50 and a 200 day moving average price of $9.18. Integral Ad Science Holding Corp. has a 52 week low of $6.26 and a 52 week high of $13.62. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.02. The business had revenue of $134.07 million for the quarter, compared to analysts' expectations of $129.20 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. Sell-side analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.